HENDERSON JANE (Chief Financial Officer) sold 1.1% of their position (2K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $180.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/18/2026ACC: 0001104659-26-045062
Officer· Chief Financial Officer
Since Mar 2026
-2K
Net shares
Net seller
$180.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$90.00
Trade value
$180K
% of position
1.1%
4/16/2026
177.37K→175.37K
Total
Net shares
−2K
Net value
-$180K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | S · Sale | −2K | $90.00 | $180K | 1.1% | 177.37K | 175.37K |
| Total | −2K | -$180K | ||||||
Derivative Transactions0
No derivative transactions reported